Unlock instant, AI-driven research and patent intelligence for your innovation.
Andrographolide derivatives and application of the same in pharmacy
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of andrographolide, derivatives, applied in antipyretic, antibacterial, antitumor and other directions
Inactive Publication Date: 2008-02-20
JINAN UNIVERSITY
View PDF0 Cites 36 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, no single mechanism is sufficient to explain its antitumor activity and perhaps each of them plays a role
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0122] Example 1. Preparation of 3,19-isopropylidene andrographolide 1
[0123] Dissolve andrographolide (150 mg, 0.43 mmol) in a mixed solution containing 2,2-dimethoxypropane (0.2 mL), pyridinium p-toluenesulfonate (3 mg) and toluene / DMSO (3 mL / 0.4 mL) , stirred at 80° C. for 1 hour, after the reaction was complete, cooled to room temperature, and quenched the reaction mixture with triethylamine (0.1 mL). The reaction mixture was diluted with toluene (20 mL), washed with water (3×5 mL), and the organic layer was washed with anhydrous Na 2 SO 4 After drying and concentration, the resulting white solid was washed with ether and filtered to obtain compound 1 (130 mg, 78%) (Srinivas et al., Bioorg. Med. Chem. Lett. 2004, 14, 4711-4717).
Embodiment 2
[0124] Example 2. Preparation of 14-lipoyl-3,19-isopropylidene andrographolide 2
[0125] Add ethyl chloroformate (0.11 mL) to α-lipoic acid (214 mg) CH 2 Cl 2 (8 mL) solution, add 0.21 mL of triethylamine, and stir at 0° C. for 1 h under the protection of nitrogen. Compound 1 (100 mg) was dissolved in CH 2 Cl 2 (8 mL), was added to the mixture, and stirred at room temperature for 2 days. Add CH after reaction 2 Cl 2 (30mL) diluted with NaHCO 3 Aqueous solution and water wash. Anhydrous NaSO for organic layer 4 Dry and concentrate in vacuo. The mixture was separated on a silica gel column to obtain compound 2 (90 mg, 61%) as a yellow crystalline powder. 1 H NMR (CDCl 3 , 400MHz): δ7.03(t, 1H, J=5.20Hz), 5.90(d, 1H, J=6.50Hz), 4.90(s, 1H), 4.20(dd, 1H, J=7.20, 17.20Hz) , 3.90 (d, 1H, J=11.99Hz), 1.42 (s, 3H), 1.37 (s, 3H), 1.21 (s, 3H), 0.81 (s, 3H). MS(ESI)[M+H] + m / z 578.
Embodiment 3
[0126] Example 3. Preparation of 14-lipoyl-3,19-dihydroxy-andrographolide AL-1
[0127] Compound 2 (100mg) was added into acidic aqueous solution (AcOH / H 2 O=7 / 3, 3 mL), stirred at room temperature for 1 h. The reaction mixture was added with water and NaHCO 3 In, use CH 2 Cl 2 (3 x 20 mL) extraction. Anhydrous NaSO for organic layer 4 Dry and concentrate in vacuo. The mixture was separated on a silica gel column to obtain compound AL-1 (42 mg, 45%) as a yellow crystalline powder. 1 H NMR (CDCl 3 , 400MHz): 7.03(t, 1H, J=5.20Hz), 5.93(d, 1H, J=6.50Hz), 4.88(s, H), 4.50(s, 1H), 4.24-4.17(dd, 1H, J=6.80, 18.40Hz), 3.34-3.32(d, 1H, J=10.79Hz), 1.34(s, 6H). HRMS[M] + m / z 538.2417, (calcd 538.2408).
[0128] Its synthetic reaction formula is as follows:
[0129]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to an andrographolide derivative, which has the structure as shown in a general formula I: wherein, R1, R2 and R3 are the same or different hydrogen, substituted or non-substituted organic acid radical, inorganic acid radical, alkyl, aryl or heteroaryl, while at least one of R1, R2 and R3 is R-lipoic acid or S-lipoic acid or the mixture of R-lipoic acid and S-lipoic acid or the corresponding dihydrolipoic acid or acetylcysteine radical of R-lipoic acid or S-lipoic acid; the derivative has good anti-tumor effect, and the derivative can cause apoptosis of tumor cells, directly eliminate gram positive bacteria, staphylococcus aureus and sensitivities MRSA5676 and MRSA5677, inhibit the QS system of gram negative bacteria and pseudomonas aeruginosa and inhibit and damage the formation of the bio-film of pseudomonas aeruginosa; the product has prominent hypoplycemic effect and is suitable for the preparation of the medicines that can cure cancers, inflammations, diabetes mellitus and bacterial and viral infection.
Description
technical field [0001] The present invention relates to new andrographolide derivatives and their application in pharmacy. Background technique [0002] Andrographolide (Andrographolide) is the main active ingredient in the traditional Chinese medicineAndrographis paniculata. Andrographis paniculata is widely used in Asian countries, including China, India, Japan, Korea, etc., to treat inflammatory diseases, including rheumatoid arthritis, pharyngitis, diarrhea, bacterial and viral infections (Zhao and Fang, Chin. Med. J. (Engl) 1991, 104, 770-775; Puri et al., J.Nat.Prod.1993, 56, 995-999; Zhang and Tan, Clin.Exp.Pharmacol.Physiol.1996, 23, 675-678; Zhang and Tan, Clin. Exp. Pharmacol. Physiol. 2000, 27, 358-363; Shen et al., Br. J. Pharmacol. 2002, 35, 399-406). Recently, studies have shown that andrographolide has broad-spectrum anticancer effects and good therapeutic effects (Rajagopal et al., J.Exp.Ther.Oncol.2003, 3, 147-158; Satyanarayana et al.Science 2003, 299, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.